Global Plastic Packaging Market: Trending in 2021
New York, NY 4 June 2021: The Plastic Packaging market size is anticipated to reach USD 416.2 billion by 2026. In 2017, the bottles segment dominated the global market, in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period. A significant increase in disposable income, changing lifestyles, and improving living standards have increased the demand for food products, consumer electronics, and retail products among others, which supports the market growth.
Initiatives by market players to offer innovative products in the market, communicate brand values, and create brand differentiation also drive the market growth. Other driving factors include growing middle class population, and increasing penetration of e-commerce platforms. The significant growth in e-commerce and rising consumer demand for consumer goods has resulted in growth in packaging segments such as protective packaging, flexible pouches and innovative bottles. Increasing demand from developing nations, and technological advancements are factors expected to provide numerous growth opportunities to the market players during the forecast period.
Large brands are focusing on personalized and customized plastic packaging to create an impact on consumers and enhance brand awareness. Packaging enables companies to differentiate brands and offer personalization. Packaging can provide links to information about the product, both enhancing the product and providing details about its provenance. Plastic packaging enables enhancing of brand power for global brands and offers an effective method to compete with private label and emerging local players. Growth in digitalization offers consumers access to vast and detailed information. Communicating brand values effectively and enabling product differentiation is a major factor driving the growth of the plastic packaging industry.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/plastic-packaging-market/request-for-sample
Asia-Pacific generated the highest revenue in the plastic packaging market in 2018, and is expected to lead the global market throughout the forecast period. The increasing population in the region coupled with growing disposable income has increased the sale of food and beverages, apparel, and consumer goods, driving the market growth. Consumers in the region are increasingly opting for packaging that is easy to use and convenient to transport. Smaller, lighter and easily disposable packaging is being used to make consumption-on-the-go easier. The growing healthcare, retail, and pharmaceutical industries in countries such as China, Japan, and India support the market growth.
The well-known companies profiled in the report include Mondi Group, Berry Plastics Corporation, Sonoco Products Company, Amcor Limited, DS Smith plc, Bemis Company, Inc., NatureWorks LLC, Consolidated Container Company, Reynolds Group Holdings Limited, and Alpla Werke Alwin Lehner GmbH & Co. KG. These companies launch new products and collaborate with other players in the global plastic packaging industry to innovate and launch new products to meet the increasing needs and requirements of consumers.
Polaris Market Research has segmented the global plastic packaging market on the basis of type, product, end user and region:
Plastic Packaging Type Outlook (Revenue, USD Billion, 2015 – 2026)
- Rigid Plastic Packaging
- Flexible Plastic Packaging
Plastic Packaging Product Outlook (Revenue, USD Billion, 2015 – 2026)
- Bags
- Cans
- Bottles
- Pouches
- Others
Plastic Packaging End User Outlook (Revenue, USD Billion, 2015 – 2026)
- Food and Beverage
- Healthcare
- Pharmaceutical
- Retail
- Personal and Home Care
- Others
To get Incredible Discounts on this Premium Report, Click At: https://www.polarismarketresearch.com/industry-analysis/plastic-packaging-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
In 2017, the bottles segment dominated the global market, in terms of revenue.
Initiatives by market players to offer innovative products in the market, communicate brand values, and create brand differentiation also drive the market growth.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/plastic-packaging-market/request-for-sample Large brands are focusing on personalized and customized plastic packaging to create an impact on consumers and enhance brand awareness.
Plastic packaging enables enhancing of brand power for global brands and offers an effective method to compete with private label and emerging local players.
Communicating brand values effectively and enabling product differentiation is a major factor driving the growth of the plastic packaging industry.
Consumers in the region are increasingly opting for packaging that is easy to use and convenient to transport.
The global plastic additives market size is expected to value at USD 62.50 billion by 2022.
Advantages of the plastic additives such as resistance to microbial activities, antioxidants, ultra-violet stabilizer, plasticizers, and impact modifiers, which are critical for compound formulations in order to enhance chemical and physical properties, are expected to foster market growth over the forecast period.Globally, the plastic additives market is predicted to grow at CAGR of 4.5% in forecast period, providing numerous opportunities for market players to invest in research and development of the market.
Additionally, increasing industrial activities, growing manufacturing output and strong economic growth in the Asia Pacific region is expected to expand market reach of the plastic additives industry over the forecast period.Favorable laws and regulation by governmental and international authorities such as EC (Beaches European Commission) and amendments in the Restriction of Hazardous Substances (RoHS) that monitors use of plasticizers, flame retardant and other additives are anticipated fuel market growth in the upcoming years.
However, excessive use of plasticizers, flame retardant and other additives causes adverse effects on human health and the environment condition, thereby restraining market growth to a certain extent.For further inquiries, about - Global Plastic Additives Industry Analysis, Size, Growth, Trends and Forecast 2012 - 2022, click on this link – https://www.millioninsights.com/industry-reports/plastic-additives-marketYet, the recent technological advancement and introduction of new methodologies for the production of the plasticizers, flame retardant and other additives are anticipated to boost market demand in the upcoming years.
Variation in the price of raw materials along with lack of availability are expected to limit market progress substantially.
Changing market dynamics regarding availability of raw material in the Middle East region are further negatively affect market growth, in the recent years.Additionally, easy availability of the alternative products such as polycarbonate (PC) and poly-acrylic (PMMA) coupled with lowered process are further affecting market performance of the plastic additives industry.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
